Literature DB >> 11932791

Post-ERCP pancreatitis: new momentum.

T Rabenstein, E G Hahn.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 11932791     DOI: 10.1055/s-2002-23651

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


× No keyword cloud information.
  12 in total

1.  Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Zahra Taherzadeh; Homayoon Sokhanvar; Tolou Hasandokht
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 2.  Indomethacin prevents post-ERCP pancreatitis in selected high-risk patients.

Authors:  Mattia Bonzi; Elisa Maria Fiorelli
Journal:  Intern Emerg Med       Date:  2012-11-02       Impact factor: 3.397

3.  A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.

Authors:  Ali A Siddiqui; Devi Patel; Jeremy Kaplan; Andrew H Zabolotsky; David Loren; Thomas Kowalski; Saad S Ghumman; Douglas G Adler; Satish Munigal; Umar Hayat; Mohamad A Eloubeidi
Journal:  Dig Dis Sci       Date:  2015-04-14       Impact factor: 3.199

4.  Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units.

Authors:  Mia Rainio; Outi Lindström; Marianne Udd; Johanna Louhimo; Leena Kylänpää
Journal:  J Gastrointest Surg       Date:  2017-04-03       Impact factor: 3.452

5.  Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis.

Authors:  Xiao-wen Zhao; Jun-jun Bao; Cui Hu; Hao Ding; Xiao-chang Liu; Qiao Mei; Jian-ming Xu
Journal:  Dig Dis Sci       Date:  2014-07-17       Impact factor: 3.199

6.  Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?

Authors:  Dennis Yang; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

7.  Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis.

Authors:  Lan Liu; Chenghao Li; Yuan Huang; Haiyan Jin
Journal:  J Gastrointest Surg       Date:  2018-09-24       Impact factor: 3.452

Review 8.  Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis.

Authors:  Hiroki Yuhara; Masami Ogawa; Yoshiaki Kawaguchi; Muneki Igarashi; Tooru Shimosegawa; Tetsuya Mine
Journal:  J Gastroenterol       Date:  2013-05-30       Impact factor: 7.527

9.  25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study.

Authors:  Takeo Yoshihara; Masayoshi Horimoto; Tetsuhisa Kitamura; Naoto Osugi; Tatsuro Ikezoe; Kaori Kotani; Toru Sanada; Churi Higashi; Daisuke Yamaguchi; Makiyo Ota; Tatsunori Mizuno; Yasukazu Gotoh; Yorihide Okuda; Kunio Suzuki
Journal:  BMJ Open       Date:  2015-03-20       Impact factor: 2.692

10.  Role of Rectal Diclofenac Suppository for Prevention and Its Impact on Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients.

Authors:  Sandeep Patil; Vikas Pandey; Nilesh Pandav; Meghraj Ingle; Aniruddha Phadke; Prabha Sawant
Journal:  Gastroenterology Res       Date:  2016-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.